COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study

BACKGROUND: Botulinum toxin A (BoNT-A) is considered a safe and effective treatment for spasticity and dystonia. Individual interinjection intervals are critical for the maintenance of the effect. In Austria, BoNT outpatient clinics were shutdown from November to December 2020 during COVID-19 contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Teuschl, Yvonne, Bancher, Christian, Brainin, Michael, Dachenhausen, Alexandra, Matz, Karl, Pinter, Michaela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541799/
https://www.ncbi.nlm.nih.gov/pubmed/34689260
http://dx.doi.org/10.1007/s00702-021-02430-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541799/
https://www.ncbi.nlm.nih.gov/pubmed/34689260
http://dx.doi.org/10.1007/s00702-021-02430-z

Ejemplares similares